These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 24239956)
1. Plasma concentrations of sAxl are associated with severe preeclampsia. Liu X; Gong Y; Jia J; Bai Y; Gui S; Wang T; Zhou R Clin Biochem; 2014 Feb; 47(3):173-6. PubMed ID: 24239956 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels of TAM receptors and ligands in severe preeclampsia. Peng S; Sun M; Sun X; Wang X; Jin T; Wang H; Han C; Meng T; Li C Pregnancy Hypertens; 2018 Jul; 13():116-120. PubMed ID: 30177037 [TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Ekman C; Jönsen A; Sturfelt G; Bengtsson AA; Dahlbäck B Rheumatology (Oxford); 2011 Jun; 50(6):1064-9. PubMed ID: 21278074 [TBL] [Abstract][Full Text] [Related]
4. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. Ekman C; Stenhoff J; Dahlbäck B J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931 [TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Ekman C; Linder A; Akesson P; Dahlbäck B Crit Care; 2010; 14(4):R158. PubMed ID: 20731857 [TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms. Ekman C; Site DF; Gottsäter A; Lindblad B; Dahlbäck B Clin Biochem; 2010 Jan; 43(1-2):110-4. PubMed ID: 19660445 [TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Ekman C; Gottsäter A; Lindblad B; Dahlbäck B Clin Biochem; 2010 Jul; 43(10-11):873-6. PubMed ID: 20417630 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction. Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801 [TBL] [Abstract][Full Text] [Related]
9. Increased concentrations of plasma growth arrest-specific 6 and its soluble tyrosine kinase receptor sAxl in Taiwanese women with pelvic inflammatory disease. Chen SC; Ko JL; Yang SF; Tsai MY; Tsai HT; Tang CH; Wang PH Clin Chim Acta; 2013 Nov; 426():85-90. PubMed ID: 24045047 [TBL] [Abstract][Full Text] [Related]
10. Possible Association of Elevated Plasma Levels of Growth Arrest-Specific Protein 6 and the Soluble Form of Tyrosine Kinase Receptor Axl with Low Hepatitis C Viral Load in Patients with Type 2 Diabetes Mellitus. Bassyouni RH; Gomaa AA; Hassan EA; Ali ESG; Khalil MAF; Mashahit MA; Gaber SN Viral Immunol; 2020 Mar; 33(2):105-111. PubMed ID: 31905327 [TBL] [Abstract][Full Text] [Related]
11. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus. Liphaus BL; Lima L; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M Clin Rheumatol; 2020 Feb; 39(2):509-514. PubMed ID: 31655933 [TBL] [Abstract][Full Text] [Related]
12. Serum GAS6, sAXL, IL-10, NO, and BCL-2 levels are decreased in patients with Behçet's disease. Baskol G; Yetkin MÖ; Sevim DG; Guclu K; Arda H; Saracoglu H; Gahramanov K; Evereklioglu C Indian J Ophthalmol; 2024 May; 72(Suppl 3):S468-S472. PubMed ID: 38648454 [TBL] [Abstract][Full Text] [Related]
13. Axl is related to inflammation in hemodialysis patients. Li M; Xue W; Li X; Song Y; Liu X; Qin L Mol Immunol; 2021 May; 133():146-153. PubMed ID: 33667984 [TBL] [Abstract][Full Text] [Related]
14. Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders. Bellan M; Dimagli A; Piccinino C; Giubertoni A; Ianniello A; Grimoldi F; Sguazzotti M; Nerviani A; Barini M; Carriero A; Smirne C; Burlone ME; Rigamonti C; Minisini R; Salmi L; Barbaglia MN; Castello LM; Sola D; Marino P; Avanzi GC; Pirisi M; Sainaghi PP Dis Markers; 2020; 2020():2696173. PubMed ID: 32454903 [TBL] [Abstract][Full Text] [Related]
15. Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis. Gong S; Xu Z; Liu Y; Xing L; Ma J; Yu C; Liu X; Jia X; Xie R; Sui M Eur J Clin Invest; 2019 Mar; 49(3):e13064. PubMed ID: 30588607 [TBL] [Abstract][Full Text] [Related]
16. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Budagian V; Bulanova E; Orinska Z; Duitman E; Brandt K; Ludwig A; Hartmann D; Lemke G; Saftig P; Bulfone-Paus S Mol Cell Biol; 2005 Nov; 25(21):9324-39. PubMed ID: 16227584 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of soluble Axl correlate with severity of community-acquired pneumonia. Ko CP; Yu YL; Hsiao PC; Yang SF; Yeh CB Mol Med Rep; 2014 Apr; 9(4):1400-4. PubMed ID: 24503651 [TBL] [Abstract][Full Text] [Related]
18. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560 [TBL] [Abstract][Full Text] [Related]
19. Diminished soluble levels of growth arrest specific protein 6 and tyrosine kinase receptor Axl in patients with rheumatoid arthritis. Bassyouni IH; El-Wakd MM; Azab NA; Bassyouni RH Int J Rheum Dis; 2017 Jan; 20(1):53-59. PubMed ID: 24702788 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Gustafsson A; Martuszewska D; Johansson M; Ekman C; Hafizi S; Ljungberg B; Dahlbäck B Clin Cancer Res; 2009 Jul; 15(14):4742-9. PubMed ID: 19567592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]